Top Financing News

The Recap

The best information on capital raises and financing activity in under 5 minutes:

• Nikon Corp. (NKN.MU) raises €170 million from Ray-Ban maker EssilorLuxottica amounting to a 5.1% stake in the company

• Americas Gold and Silver (TSX: USA / NYSE: USAS) announces upsize of previously announced private placement of subscription receipts to CAD $45 million

• Scholar Rock Holding Corporation (NASDAQ:SRRK) announces pricing on its upsized $300 million public offering of common stock and pre-funded warrants

EssilorLuxottica, the maker of Ray-Ban, has acquired a 5.1% stake in Nikon, amounting to a €170 million (~$184 million) investment. This move strengthens the relationship between the two companies, which began in 2000 with the creation of Nikon-Essilor, a joint venture focused on wholesale lens production. This investment highlights the continued collaboration in serving both regional and global markets. Lenses have become a critical component in advancing new and emerging technologies. EssilorLuxottica has a long-term partnership with Meta Platforms Inc., through its Ray-Ban brand, to co-develop innovative smart wearable products. We believe it is possible that this recent investment helps pave the way for Nikon to participate in smart wearable products in the future.

Americas Gold and Silver has upsized its previously announced private placement of subscription receipts to CAD$45 million. Americas is a high‐growth precious metals mining company with multiple assets in North America. The Company owns and operates the Cosalá Operations in Sinaloa, Mexico, manages the 60%‐owned Galena Complex in Idaho, USA, and is re‐evaluating the Relief Canyon mine in Nevada, USA. The Company also owns the San Felipe development project in Sonora, Mexico.

Following positive Phase 3 data showing muscle improvement in spinal muscular atrophy, Scholar Rock raised $300 million through a blend of pre-funded warrants and common stock. The company now plans to submit the drug for U.S. and European regulatory approval in early 2025. Scholar Rock is a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role.

Weekly Money Moves

Lead Investors

• Pfizer: $1,000,000,000 | Biotechnology | Lead Investor: Starboard Value

• Ixico: $5,235,582 | Biotechnology | Lead Investor: Gresham House

• Inhibikase Therapeutics: $110,000,000 | Health Care | Lead Investor: Soleus Capital

• NUBURU: $65,000,000 | Manufacturing | Lead Investor: Liqueous LP

• NextSource Materials: $10,674,994 | Mining | Lead Investor: Vision Blue Resources

• Abcourt Mines: $1,251,999 | Mining | Lead Investor: NQ Investissement Minier

• Nikon: $184,000,000 | Photography | Lead Investor: EssilorLuxottica

• Orsted: $2,500,000,000 | Renewable Energy | Lead Investor: Equinor

• Skyx Platforms: $11,000,000 | Technology | Lead Investor: Lance T. Shaner

Do you know of any other lead investors who put capital into the markets this week? We would be happy to feature the transactions, send us an email at [email protected]